TITLE

A02 Visualisation of mutant huntingtin oligomerisation in living cells

AUTHOR(S)
Herrera, F; Tenreiro, S; Fleming Outeiro, T
PUB. DATE
September 2010
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Sep2010 Supp, Vol. 81, pA1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background Aggregation of mutant huntingtin is a dynamic process that starts with the association of a few misfolded huntingtin monomers in small, soluble oligomeric structures. Current evidence suggests that dimers and oligomers are the most toxic species of mutant huntingtin and that the largest aggregates are rather neuroprotective. In order to prevent huntingtin aggregation and toxicity it is essential to understand the molecular mechanisms of oligomerisation. However, existing experimental models of Huntington's disease do not enable the direct visualisation of the smaller intermediary species in the aggregation process, only of the larger huntingtin aggregates. Aims To develop a cellular model for the visualisation and study of dimers and oligomers of mutant huntingtin in living cells. Methods We generated two different constructs that carried complementary portions of the Venus fluorescent reporter protein fused to the exon 1 of mutant huntingtin (103Q glutamine tract). When the exon-1 of mutant huntingtin dimerises inside the cells, both complementary halves of Venus reconstitute the functional fluorophore and emit green fluorescence, which can be easily visualised and measured. Results Oligomer generation and toxicity was evaluated over time and confirmed by different methods. We used similar fusion constructs with wild-type huntingtin exon 1 (25Q glutamine tract) as a negative control for oligomerisation and toxicity. Additional controls included, among others, the transfection of cells with only one of the constructs or with the two halves of the Venus protein without huntingtin. The robustness of our model is being tested by analysing the effect of known modifiers of aggregation, such as heat shock proteins, on huntingtin oligomerisation. Conclusions Our preliminary results indicate that this model can be a powerful tool for the identification of new molecular targets for the treatment of Huntington's disease.
ACCESSION #
66321948

 

Related Articles

  • Kinase inhibitors modulate huntingtin cell localization and toxicity. Atwal, Randy Singh; Desmond, Carly R.; Caron, Nicholas; Maiuri, Tamara; Xia, Jianrun; Sipione, Simonetta; Truant, Ray // Nature Chemical Biology;Jul2011, Vol. 7 Issue 7, p453 

    Two serine residues within the first 17 amino acid residues of huntingtin (N17) are crucial for modulation of mutant huntingtin toxicity in cell and mouse genetic models of Huntington's disease. Here we show that the stress-dependent phosphorylation of huntingtin at Ser13 and Ser16 affects N17...

  • Huntingtin Aggregation Kinetics and Their Pathological Role in a Drosophila Huntington's Disease Model. Weiss, Kurt R.; Kimura, Yoko; Wyan-Ching Mimi Lee; Littleton, J. Troy // Genetics;Feb2012, Vol. 190 Issue 2, p581 

    Huntington's disease is a neurodegenerative disorder resulting from expansion of a polyglutamine tract in the Huntingtin protein. Mutant Huntingtin forms intracellular aggregates within neurons, although it is unclear whether aggregates or more soluble forms of the protein represent the...

  • Huntington's Metabolic Sequelae. Breindl, Anette // BioWorld Today;4/11/2011, Vol. 22 Issue 69, Special section p2 

    The article shows that mutant huntingtin affects the hypothalamus, according to a study from Lund University, published in the April 2011 issue of the periodical "Cell Metabolism."

  • Huntingtin inhibits caspase-3 activation. Yu Zhang; Leavitt, Blair R.; van Raamsdonk, Jeremy M.; Dragatsis, Ioannis; Goldowitz, Dan; MacDonald, Marcy E.; Hayden, Michael R.; Friedlander, Robert M. // EMBO Journal;12/13/2006, Vol. 25 Issue 24, p5896 

    Huntington's disease results from a mutation in the HD gene encoding for the protein huntingtin. The function of huntingtin, although beginning to be elucidated, remains largely unclear. To probe the prosurvival function of huntingtin, we modulate levels of wild-type huntingtin in a number of...

  • Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD. Bowles, Kathryn R.; Brooks, Simon P.; Dunnett, Stephen B.; Jones, Lesley // PLoS ONE;12/14/2015, Vol. 10 Issue 12, p1 

    Huntington’s disease is a neurodegenerative disorder characterised primarily by motor abnormalities, and is caused by an expanded polyglutamine repeat in the huntingtin protein. Huntingtin dynamically shuttles between subcellular compartments, and the mutant huntingtin protein is...

  • Live cell imaging and biophotonic methods reveal two types of mutant huntingtin inclusions. Caron, Nicholas S.; Hung, Claudia L.; Atwal, Randy S.; Truant, Ray // Human Molecular Genetics;May2014, Vol. 23 Issue 9, p2324 

    Huntington's disease (HD) is an autosomal dominant, neurodegenerative disorder that can be characterized by the presence of protein inclusions containing mutant huntingtin within a subset of neurons in the brain. Since their discovery, the relevance of inclusions to disease pathology has been...

  • Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction. Weiss, Andreas; Roscic, Ana; Paganetti, Paolo // Molecular Neurodegeneration;2009, Vol. 4, p1 

    Background: Expansion of a polyglutamine repeat at the amino-terminus of huntingtin is the probable cause for Huntington's disease, a lethal progressive autosomal-dominant neurodegenerative disorders characterized by impaired motor performance and severe brain atrophy. The expanded polyglutamine...

  • Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. Tsvetkov, Andrey S; Arrasate, Montserrat; Barmada, Sami; Ando, D Michael; Sharma, Punita; Shaby, Benjamin A; Finkbeiner, Steven // Nature Chemical Biology;Sep2013, Vol. 9 Issue 9, p586 

    In polyglutamine (polyQ) diseases, only certain neurons die, despite widespread expression of the offending protein. PolyQ expansion may induce neurodegeneration by impairing proteostasis, but protein aggregation and toxicity tend to confound conventional measurements of protein stability. Here,...

  • NEURODEGENERATIVE DISORDERS: Out of the inclusion zone. López, Juan Carlos // Nature Reviews Neuroscience;Jan2002, Vol. 3 Issue 1, p5 

    Discusses the results of two studies on the dissociation between nuclear inclusion of mutant huntingtin and striatal cell death in Huntington's disease. Observations on the expression of wild-type huntingtin; Role of protein aggregates in neuronal dysfunction; Overview of other studies on...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics